Segmedica, a division of Research America Inc., and Endo Pharmaceuticals are thrilled to announce their recognition by Quirk’s as finalists for the Health Care / Pharmaceutical Research Project Award.
Segmedica, a division of Research America Inc., VP, Barbara Haimowitz, PhD, will be co-presenting the results of the Intellus Clear Health Communication Taskforce’s (CHCT) research.
Segmedica (xsperient®) and Research America Inc. Announce Merger of Companies Segmedica, is pleased to announce that as of January 4th
Segmedica’s Dr. Barbara Haimowitz will be presenting HealthVoiceTM: Digging Deeper Into The Patient – Doctor Dialogue at the Intellus Worldwide Institute, in Boston Setember 27th.
Research America, the parent company of Segmedica, announces recognition from Quirk’s as part of the 22 Top Health Care Research Companies.
Segmedica has been selected to present at the 2021 Food & Nutrition Conference & Expo™ (FNCE®). The presentation, Cart to Counter: Leveraging Personality Data and Technology to Boost the Grocery Experience, is scheduled for Sunday, October 17th at 11:30AM – 12:30PM CT.
Segmedica has be invited to present in an online forum conducted by DTC Perspectives, an expert events and content provider in the field.
Segmedica is presenting a paper, Achieving and Using a Great Segmentation, in the early afternoon of May 12th.
Segmedica to Present at the 2021 Intellus Summit Join Segmedica at the Intellus Summit Virtual Event in April. We will
Segmedica Launches Telepsychiatry in the Age of COVID-19 In this new ConnexionPoints® report, we provide an up-to-date view of telepsychiatry
Segmedica Launches Modeling Consumer Behavior within Healthcare During COVID-19 In this new ConnexionPoints® report, we used qualitative research and psychology
Segmedica Launches RapidConnexion™ Personal Care and Beauty Series These studies are brief but insightful and designed to bring you up
